Human host factors required for influenza virus replication R König, S Stertz, Y Zhou, A Inoue, HH Hoffmann, S Bhattacharyya, ... Nature 463 (7282), 813-817, 2010 | 964 | 2010 |
Meta-and orthogonal integration of influenza “OMICs” data defines a role for UBR4 in virus budding S Tripathi, MO Pohl, Y Zhou, A Rodriguez-Frandsen, G Wang, DA Stein, ... Cell host & microbe 18 (6), 723-735, 2015 | 904 | 2015 |
Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation SP Reid, LW Leung, AL Hartman, O Martinez, ML Shaw, C Carbonnelle, ... Journal of virology 80 (11), 5156-5167, 2006 | 556 | 2006 |
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins MS Park, ML Shaw, J Munoz-Jordan, JF Cros, T Nakaya, N Bouvier, ... Journal of virology 77 (2), 1501-1511, 2003 | 456 | 2003 |
Cellular proteins in influenza virus particles ML Shaw, KL Stone, CM Colangelo, EE Gulcicek, P Palese PLoS pathogens 4 (6), e1000085, 2008 | 424 | 2008 |
Transcription elongation can affect genome 3D structure S Heinz, L Texari, MGB Hayes, M Urbanowski, MW Chang, N Givarkes, ... Cell 174 (6), 1522-1536. e22, 2018 | 372 | 2018 |
Orthomyxoviridae ML Shaw, P Palese Fields virology 1, 1151-1185, 2013 | 325 | 2013 |
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose C Kuhlmann, CK Mayer, M Claassen, T Maponga, WA Burgers, R Keeton, ... The Lancet 399 (10325), 625-626, 2022 | 304 | 2022 |
Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively ML Shaw, A García-Sastre, P Palese, CF Basler Journal of virology 78 (11), 5633-5641, 2004 | 260 | 2004 |
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis HH Hoffmann, A Kunz, VA Simon, P Palese, ML Shaw Proceedings of the National Academy of Sciences 108 (14), 5777-5782, 2011 | 254 | 2011 |
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus-and toll-like receptor 3-triggered signaling pathways ML Shaw, WB Cardenas, D Zamarin, P Palese, CF Basler Journal of virology 79 (10), 6078-6088, 2005 | 226 | 2005 |
Functional landscape of SARS-CoV-2 cellular restriction L Martin-Sancho, MK Lewinski, L Pache, CA Stoneham, X Yin, ME Becker, ... Molecular cell 81 (12), 2656-2668. e8, 2021 | 172 | 2021 |
Baloxavir marboxil: the new influenza drug on the market R O’Hanlon, ML Shaw Current opinion in virology 35, 14-18, 2019 | 150 | 2019 |
Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism MJ Ciancanelli, VA Volchkova, ML Shaw, VE Volchkov, CF Basler Journal of virology 83 (16), 7828-7841, 2009 | 137 | 2009 |
A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant L Martinez-Gil, PH Goff, R Hai, A Garcia-Sastre, ML Shaw, P Palese Journal of virology 87 (3), 1290-1300, 2013 | 136 | 2013 |
Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity HH Hoffmann, P Palese, ML Shaw Antiviral research 80 (2), 124-134, 2008 | 119 | 2008 |
Uncovering the global host cell requirements for influenza virus replication via RNAi screening S Stertz, ML Shaw Microbes and infection 13 (5), 516-525, 2011 | 107 | 2011 |
Nipah virus edits its P gene at high frequency to express the V and W proteins S Kulkarni, V Volchkova, CF Basler, P Palese, VE Volchkov, ML Shaw Journal of virology 83 (8), 3982-3987, 2009 | 91 | 2009 |
Fields virology P Palese, ML Shaw Orthomyxoviridae: The Viruses and Their Replication, 5th edn, Philadelphia …, 2007 | 91 | 2007 |
Paramyxovirus V proteins interact with the RIG-I/TRIM25 regulatory complex and inhibit RIG-I signaling MT Sanchez-Aparicio, LJ Feinman, A García-Sastre, ML Shaw Journal of virology 92 (6), 10.1128/jvi. 01960-17, 2018 | 82 | 2018 |